Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Maravai Lifesciences Holdings (MRVI) Short-term Investments (2024)

Maravai Lifesciences Holdings has reported Short-term Investments over the past 1 years, most recently at $1.4 million for Q4 2024.

Quarterly results put Short-term Investments at $1.4 million for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $1.4 million (changed N/A YoY), and the annual figure for FY2024 was $1.4 million, changed.
Short-term Investments for Q4 2024 was $1.4 million at Maravai Lifesciences Holdings, down from $6.6 million in the prior quarter.
Over the last five years, Short-term Investments for MRVI hit a ceiling of $6.6 million in Q2 2024 and a floor of $1.4 million in Q4 2024.